Efficacy and safety of (177)Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study

PURPOSE: NETTER-R aimed to determine the efficacy, safety and tolerability of (177)Lu-DOTATATE in patients with progressive, advanced pancreatic neuroendocrine tumours (panNETs) using retrospective real-world data from multiple sites. METHODS: This international study retrospectively included patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Clement, Dominique, Navalkissoor, Shaunak, Srirajaskanthan, Rajaventhan, Courbon, Frédéric, Dierickx, Lawrence, Eccles, Amy, Lewington, Valerie, Mitjavila, Mercedes, Percovich, Juan Carlos, Lequoy, Benoît, He, Beilei, Folitar, Ilya, Ramage, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308585/
https://www.ncbi.nlm.nih.gov/pubmed/35389069
http://dx.doi.org/10.1007/s00259-022-05771-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308585/
https://www.ncbi.nlm.nih.gov/pubmed/35389069
http://dx.doi.org/10.1007/s00259-022-05771-3

Ejemplares similares